Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89032413

APP, anti-Human, Clone: WO2, Abnova™

Catalog No. 89032413 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-032-413 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-032-413 Supplier Abnova Corporation Supplier No. RAB00070
Only null left
Add to Cart
Add to Cart

Description

Monoclonal Antibody

Specifications

Antigen APP
Applications ELISA, Immunohistochemistry (Paraffin), Western Blot
Classification Monoclonal
Clone WO2
Conjugate Unconjugated
Dilution ELISA (0.1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (5 ug/mL) Western Blot (1 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In PBS, pH 7.2 (0.02% Proclin 300).
Gene amyloid beta (A4) precursor protein
Gene Alias AAA/ABETA/ABPP/AD1/APPI/CTFgamma/CVAP/PN2
Gene Symbols APP
Immunogen Original antibody is raised against a synthetic peptide of human Amyloid beta.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 351
Test Specificity This antibody recognizes acid residues 4-10 of human Amyloid beta.
Target Species Human
Content And Storage Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Product Type Antibody
Form Liquid
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.